Cardiovascular
Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide. At Boehringer Ingelheim we address unmet medical need by providing innovative treatments that improve the care of patients suffering from a range of cardiovascular conditions including irregular heart beats (atrial fibrillation), stroke, blood clots in deep veins or lungs (deep vein thrombosis or pulmonary embolism), high blood pressure (hypertension) or heart attack (myocardial infarction).
-
Geog van Husen
Cardiovascular
Dr. Georg van Husen, Therapeutic Area Head Cardiovascular
-
-
Innovation and Healthcare
Find out more about our new pilot stroke rehabilitation Consanas.
-
Angels Initiative
Stroke Care
Learn more about the unique healthcare initiative to improve care for people who have just suffered a stroke across Europe and in emerging markets
-
-
Eve's Story
DVT/PE
-
Angels Initiative
Acute Ischaemic Stroke
We are working together with our partners such as the ESO and various local societies, academics and industry partners towards a common goal, to improve care for as many people as possible who have suffered a stroke.
-
AF Patient Preferences Survey - Introduction
Stroke Prevention
Introduction, objectives and overview of the patient population in the AF Patient Preferences Survey
-
Stroke Prevention